TissUse GmbH

Activities: Research & Development Analysis

Trending Articles

  1. Catalent Boston adds to oral spray drying capacity to support late-stage clinical trials and commercialisation Catalent, the leading provider of oral drug development solutions, bioavailability enhancing technologies and flexible manufacturing, has completed a series of upgrades to its...
  2. £20m Scottish oligonucleotide manufacturing innovation centre now under construction The centre will act as an innovation centre, assisting in the development and optimisation of oligonucleotide manufacturing processes, while also bolstering the UK's...
  3. Novo Nordisk invests DKK 8.5bn into new Danish modular production site This is the first time this century that Novo Nordisk has invested into its Danish production capabilities, with the site being capable of manufacturing product types within...
  4. Scinai Immunotherapeutics establishes Delaware-based US CDMO subsidiary The biopharmaceutical company now operates contract development and manufacturing services in both Jerusalem and Delaware
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Merck jumps on the GLP-1 therapeutic bandwagon by licensing Hansoh Pharma's HS-10535 Merck will be responsible for the development, manufacture and commercialisation of the investigational preclinical oral GLP-1 receptor agonist

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Research & Development

PMI and TissUse collaborate on human aerosol test platform

The companies aim to combine their complementary technologies and expertise
Media

TissUse establishes a multi-organ model for risk assessment with Bayer

The biotechnology company has signed a collaboration agreement with the pharmaceutical and life sciences company to develop a liver-endocrine tissue assay
Research & Development

Miniaturised organ equivalents for drug testing

Dr Reyk Horland, VP Business Development of TissUse, speaks to Angharad Baldwin of <i>Manufacturing Chemist</i> about a powerful new tool that has the potential to predict toxicity or efficacy early on in the drug development process
Research & Development

TissUse reports progress made in collaboration with AstraZeneca

TissUse continues its successful collaboration with AstraZeneca to establish relevant microphysiological system (MPS) models based on TissUse’s multi-organ-chip technology
Subscribe now